mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0007 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |